|
Navigation
Recherche
|
Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs
mercredi 23 avril 2025, 11:00 , par Wired: Cult of Mac
Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.
https://www.wired.com/story/glp-1-compounding-fda-lawsuits/
|
59 sources (15 en français)
Date Actuelle
mer. 19 nov. - 09:53 CET
|
Lire la suite sur Wired: Cult of Mac